Tham and Inomax drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tham (tromethamine) and Inomax (nitric oxide). Common drug interactions include blood ph decreased among females and cardiac arrest among males.

The phase IV clinical study analyzes what interactions people have when they take Tham and Inomax. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Tham?

Tham has active ingredients of tromethamine. eHealthMe is studying from 35 Tham users. Check the latest studies of Tham.

What is Inomax?

Inomax has active ingredients of nitric oxide. eHealthMe is studying from 1,430 Inomax users. Check the latest studies of Inomax.



On Aug, 03, 2026

17 people who take Tham and Inomax together, and have interactions are studied.

Tham and Inomax drug interactions.

What are the common drug interactions of Tham and Inomax, by gender? *:

female:

  1. Blood ph decreased
  2. Cardiac arrest
  3. Cardiac arrest neonatal
  4. Cardiac output decreased
  5. Hypotension (abnormally low blood pressure)
  6. Medical device complication
  7. Methaemoglobinaemia (a disorder characterized by the presence of a higher than normal level of methemoglobin in blood)

male:

  1. Cardiac arrest
  2. Hypoxia (low oxygen in tissues)
  3. Intraventricular haemorrhage (intraventricular bleeding)
  4. Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)
  5. Sepsis (a severe blood infection that can lead to organ failure and death)
  6. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  7. Bradycardia (abnormally slow heart action)
  8. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  9. Cardiopulmonary failure (cessation of normal circulation of the blood due to failure of the heart to contract)
  10. Circulatory collapse

What are the common drug interactions of Tham and Inomax, by age (0-1 to 60+)? *:

0-1:

  1. Hypotension (abnormally low blood pressure)
  2. Hypoxia (low oxygen in tissues)
  3. Medical device complication
  4. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  5. Methaemoglobinaemia (a disorder characterized by the presence of a higher than normal level of methemoglobin in blood)
  6. Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)
  7. Sepsis (a severe blood infection that can lead to organ failure and death)
  8. Blood ph decreased
  9. Bradycardia (abnormally slow heart action)
  10. Cardiac arrest

2-9:

  1. Cardiac arrest

10-19:

  1. Cardiac arrest neonatal

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

  1. Oxygen Saturation Decreased: 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Tham and Inomax?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Tham and Inomax:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Tham:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Inomax:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tham and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Inomax and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on tromethamine and nitric oxide (the active ingredients of Tham and Inomax, respectively), and Tham and Inomax (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: